By Devika Patel
Knoxville, Tenn., Aug. 13 - Bond Laboratories, Inc. completed a $200,000 third tranche of a private placement of 10% cumulative perpetual series B preferred stock on Aug. 4, according to an 8-K filed Thursday with the Securities and Exchange Commission.
The company sold $1.25 million of the preferreds to Vicis Capital Master Fund in an initial tranche on Dec. 31. It raised $783,000 in the second tranche on April 20.
The company sold 125 preferreds at $10,000 apiece in the first tranche. It sold 78.3 preferreds to 10 investors in the second tranche and 20 preferreds in this tranche.
Vicis was the sole investor in the latest tranche and has invested a total of $1.95 million thus far. Vicis also received 7.5 million common shares in the first tranche and 1.2 million shares in the third tranche.
Bond Laboratories, based in Solana Beach, Calif., is a marketer of healthy food and beverage products.
| Issuer: | Bond Laboratories, Inc.
|
| Issue: | Cumulative perpetual series B preferred stock, 8.7 million common shares
|
| Amount: | $2,233,000
|
| Shares: | 223.3
|
| Price: | $10,000
|
| Dividends: | 10%
|
| Warrants: | No
|
| Investor: | Vicis Capital Master Fund (for $1.95 million)
|
| Settlement dates: | Dec. 31 (for $1.25 million), April 20 (for $783,000), Aug. 4 (for $200,000)
|
| Stock symbol: | OTCBB: BNLB
|
| Stock price: | $0.15 at close Dec. 31
|
| Market capitalization: | $14.4 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
